SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001607062-19-000157
Filing Date
2019-04-16
Accepted
2019-04-16 16:46:18
Documents
74
Period of Report
2019-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A gnbt013119form10qa.htm 10-Q/A 1567482
8 GRAPHIC image_001.jpg GRAPHIC 5829
9 EXHIBIT 31.1 ex31_1.htm EX-31.1 14030
10 EXHIBIT 31.2 ex31_2.htm EX-31.2 14125
11 EXHIBIT 32 ex32.htm EX-32 3813
  Complete submission text file 0001607062-19-000157.txt   7440478

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE gnbt-20190131.xml EX-101.INS 1490695
3 XBRL SCHEMA FILE gnbt-20190131.xsd EX-101.SCH 61083
4 XBRL CALCULATION FILE gnbt-20190131_cal.xml EX-101.CAL 56169
5 XBRL DEFINITION FILE gnbt-20190131_def.xml EX-101.DEF 325052
6 XBRL LABEL FILE gnbt-20190131_lab.xml EX-101.LAB 324633
7 XBRL PRESENTATION FILE gnbt-20190131_pre.xml EX-101.PRE 400630
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-Q/A | Act: 34 | File No.: 000-25169 | Film No.: 19751404
SIC: 2834 Pharmaceutical Preparations